PRecIsion Medicine in CardiomyopathY

NCT04036799 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 572

Last updated 2025-05-21

Study results available
· View outcomes & findings →

Summary

This is a retrospective cohort study of pediatric hypertrophic cardiomyopathy (HCM) patients using chart and registry review methodology. The studies objective is to develop and validate a sudden cardiac death (SCD) risk calculator that is age-appropriate for children with HCM that includes clinical and genetic factors.

Conditions

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • New York Presbyterian Hospital

    collaborator OTHER
  • University of Texas Southwestern Medical Center

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER
  • Provincial Health Services Authority

    collaborator OTHER
  • Stollery Children's Hospital

    collaborator OTHER
  • Children's Hospital of Eastern Ontario

    collaborator OTHER
  • Royal Children's Hospital

    collaborator OTHER
  • Children's Healthcare of Atlanta

    collaborator OTHER
  • Primary Children's Hospital

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • Monroe Carell Jr. Children's Hospital at Vanderbilt

    collaborator OTHER
  • Children's Hospital Colorado

    collaborator OTHER
  • Indiana University Health

    collaborator OTHER
  • OHSU Doernbecher Children's Hospital

    collaborator OTHER
  • Children's Hospital Los Angeles

    collaborator OTHER
  • The Hospital for Sick Children

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-06-01
Completion
2026-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04036799 on ClinicalTrials.gov